ZYNRELEF™ Bupivacaine / Meloxicam 400 mg - 12 mg Solution Single-Dose Vial 14 mL

Compare

McKesson #

1191472

Manufacturer #

47426030102

Brand

ZYNRELEF™

Manufacturer

Heron Therapeutics

Country of Origin

Unknown

Application

Local Anesthetic

Container Type

Single-Dose Vial

Dosage Form

Solution

Generic Drug Code

49673

Generic Drug Name

Bupivacaine / Meloxicam

NDC Number

47426030102

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

400 mg - 12 mg

Type

Extended Release

UNSPSC Code

51271603

Volume

14 mL

Manufacturer recommends ordering 1CT of each replacement kit (MMS items: 1189025, 1189026, 1189027) at time of initial ZYNRELEF order
ZYNRELEF is indicated in adults for soft tissue or periarticular instillation to produce postsurgical analgesia for up to 72 hours after bunionectomy, open inguinal herniorrhaphy, and total knee arthroplasty
ZYNRELEF is the first and only extended-release dual-acting local anesthetic™ (DALA™) and delivers 72 hours of postoperative pain relief